How to ID Patients with Difficult-to-Control Asthma

Program Overview

Understanding the mechanisms of disease has dramatically shifted our therapeutic strategies and methods of patient stratification when treating asthma. The advent of new clinical biomarkers, differential understanding of phenotypes and endotypes, and the introduction of biologics has come with questions of patient selection and suitability for novel treatment strategies. This activity combines the powerful impact of artistic design, infographic presentation, and scientific expertise to deliver the latest in asthma pathophysiology, disease heterogeneity, and biomarker understanding to help inform optimal treatment selection.

Credit Expired

CE Credit Expired

Target Audience

The target audience for this activity is pulmonary and allergy/immunology providers including physicians, nurse practitioners, and physician assistants who manage patients with asthma.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Distinguish between the different types of asthma based on underlying pathophysiology and biomarkers of disease in order to make personalized treatment decisions
Identify patients with poorly-controlled or difficult-to-treat asthma who are eligible for step up therapies, including new and emerging biologics

Activity Faculty

Bradley E. Chipps, MD, FAAP, FACAAI, FAAAAI, FCCP

Past-President, American College of Allergy, Asthma & Immunology
Medical Director, Capital Allergy & Respiratory Disease Center
Sacramento, CA

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 